CD8A and COVID-19: Likewise, the novel mRNA vaccine platform by Aunins et al. [11], which specifically aims to enhance CD8+ T cell responses, reports deficiencies with the inherent adjuvants of the COVID-19 mRNA vaccines and how this affects cellular immunity.